ReviewClinical pharmacology and therapeutics2023

Inclusion of Transgender and Gender Diverse People in Phase III Trials: Examples from HIV Pharmacologic Prevention Studies.

Lauren R Cirrincione et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.